id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-N-1309-72018,FDA,FDA-2021-N-1309,TAB C 2015-1104 Cigar Flavors PRIA as Cleared by OMB,Supporting & Related Material,Background Material,2022-09-14T04:00:00Z,2022,9,,,2022-09-14T20:38:50Z,,0,0,09000064852f7f3a
FDA-2021-N-1309-72013,FDA,FDA-2021-N-1309,TAB A 2015-1104 Cigar Flavors NPRM as Submitted to OMB,Supporting & Related Material,Background Material,2022-09-13T04:00:00Z,2022,9,,,2022-09-13T15:46:14Z,,0,0,09000064852f7f11
FDA-2021-N-1309-72015,FDA,FDA-2021-N-1309,TAB B 2015-1104 Cigar Flavors NPRM Track Changes,Supporting & Related Material,Background Material,2022-09-13T04:00:00Z,2022,9,,,2022-09-13T15:47:36Z,,0,0,09000064852f7f32
FDA-2021-N-1309-72012,FDA,FDA-2021-N-1309,Memorandum to FDA DMS on Cigar Flavors Proposed Rule (Docket No. FDA-2021-N-1309),Supporting & Related Material,Background Material,2022-09-13T04:00:00Z,2022,9,,,2022-09-13T15:46:09Z,,0,0,09000064852f7f0c
FDA-2021-N-1309-72014,FDA,FDA-2021-N-1309,TAB A 2015-1104 Cigar Flavors PRIA as Submitted to OMB,Supporting & Related Material,Background Material,2022-09-13T04:00:00Z,2022,9,,,2022-09-13T15:46:24Z,,0,0,09000064852f7f31
FDA-2021-N-1309-72017,FDA,FDA-2021-N-1309,TAB C 2015-1104 Cigar Flavors NPRM as Cleared by OMB,Supporting & Related Material,Background Material,2022-09-13T04:00:00Z,2022,9,,,2022-09-13T15:50:19Z,,0,0,09000064852f7f37
FDA-2021-N-1309-72016,FDA,FDA-2021-N-1309,TAB B 2015-1104 Cigar Flavors PRIA Track Changes,Supporting & Related Material,Background Material,2022-09-13T04:00:00Z,2022,9,,,2022-09-13T15:48:57Z,,0,0,09000064852f7f35
FDA-2021-N-1309-72011,FDA,FDA-2021-N-1309,Tribal Consultation Tobacco Product Standards Proposed Rules - Transcript Final,Other,Transcript(s),2022-08-18T04:00:00Z,2022,8,2022-08-18T04:00:00Z,,2022-08-18T16:22:09Z,,0,0,090000648524f18a
FDA-2021-N-1309-71990,FDA,FDA-2021-N-1309,FDA CTP Listening Session Transcript 06/15/2022,Other,Transcript(s),2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,,2022-08-05T19:11:31Z,,0,0,090000648521aebc
FDA-2021-N-1309-71989,FDA,FDA-2021-N-1309,FDA CTP Listening Session Transcript 06/13/2022,Other,Transcript(s),2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,,2022-08-05T19:09:05Z,,0,0,090000648521aeba
FDA-2021-N-1309-50922,FDA,FDA-2021-N-1309,Establishment of Tobacco Product Standards for Menthol in Cigarettes and Characterizing Flavors in Cigars; Extension of Comment Period,Proposed Rule,Extension of Comment Period,2022-06-21T04:00:00Z,2022,6,2022-06-21T04:00:00Z,,2022-06-21T13:16:53Z,2022-13209,0,0,090000648517e4c9
FDA-2021-N-1309-29542,FDA,FDA-2021-N-1309,"Request for Extension from Spalding Group, Inc.",Other,Request for Extension,2022-06-08T04:00:00Z,2022,6,2022-06-15T04:00:00Z,,2022-06-15T15:25:19Z,,0,0,090000648514f846
FDA-2021-N-1309-29541,FDA,FDA-2021-N-1309,"Request for Extension from The National Association of Convenience Stores (NACS), et al.",Other,Request for Extension,2022-06-03T04:00:00Z,2022,6,2022-06-15T04:00:00Z,,2022-06-15T15:22:46Z,,0,0,090000648512fbd7
FDA-2021-N-1309-10937,FDA,FDA-2021-N-1309,"Request for Extension from Cheyenne International, LLC",Other,Request for Extension,2022-05-23T04:00:00Z,2022,5,2022-05-26T04:00:00Z,,2022-05-26T14:36:14Z,,0,0,09000064850d44d9
FDA-2021-N-1309-10938,FDA,FDA-2021-N-1309,"Request for Extension from Xcaliber International, Ltd., LLC",Other,Request for Extension,2022-05-23T04:00:00Z,2022,5,2022-05-26T04:00:00Z,,2022-05-26T14:35:30Z,,0,0,09000064850d449f
FDA-2021-N-1309-0649,FDA,FDA-2021-N-1309,"Request for Extension from SWI-DE, LLC d/b/a Drew Estate",Other,Request,2022-05-19T04:00:00Z,2022,5,2022-05-23T04:00:00Z,,2022-05-23T21:27:56Z,,0,0,0900006485098aeb
FDA-2021-N-1309-0500,FDA,FDA-2021-N-1309,Request to Close Dockets After 60 Days and Not Extend the Deadline for Comments,Other,Request,2022-05-16T04:00:00Z,2022,5,2022-05-17T04:00:00Z,,2022-05-17T20:47:26Z,,0,0,0900006485081ba9
FDA-2021-N-1309-0489,FDA,FDA-2021-N-1309,"Request for Extension from Gibson, Dunn & Crutcher LLP on behalf of Swisher International, Inc.",Other,Request for Extension,2022-05-12T04:00:00Z,2022,5,2022-05-12T04:00:00Z,,2022-05-12T17:47:31Z,,0,0,09000064850734a3
FDA-2021-N-1309-0488,FDA,FDA-2021-N-1309,"Request for Extension from National Tobacco Company, LP",Other,Request for Extension,2022-05-11T04:00:00Z,2022,5,2022-05-11T04:00:00Z,,2022-05-12T00:58:27Z,,0,0,0900006485071c9e
FDA-2021-N-1309-0485,FDA,FDA-2021-N-1309,"Request for Extension from Coalition of Independent Tobacco Manufacturers of
America",Other,Request for Extension,2022-05-11T04:00:00Z,2022,5,2022-05-11T04:00:00Z,,2022-05-12T00:42:04Z,,0,0,090000648507050e
FDA-2021-N-1309-0479,FDA,FDA-2021-N-1309,"Request for Extension from The National Association for Tobacco Outlet, Inc. (NATO)",Other,Request for Extension,2022-05-10T04:00:00Z,2022,5,2022-05-10T04:00:00Z,,2022-05-13T16:56:04Z,,0,0,09000064850670e9
FDA-2021-N-1309-0475,FDA,FDA-2021-N-1309,Request for Withdrawal of Proposed Rule; Request for Extension of The Comment Period,Other,Request,2022-05-09T04:00:00Z,2022,5,2022-05-10T04:00:00Z,,2022-05-12T16:57:15Z,,0,0,090000648506163b
FDA-2021-N-1309-0478,FDA,FDA-2021-N-1309,Request for Extension from SMCI Holdings Inc (Swedish Match),Other,Request for Extension,2022-05-09T04:00:00Z,2022,5,2022-05-10T04:00:00Z,,2022-05-12T16:57:12Z,,0,0,09000064850643ad
FDA-2021-N-1309-0477,FDA,FDA-2021-N-1309,Request for Extension from Altria Client Services LLC,Other,Request for Extension,2022-05-09T04:00:00Z,2022,5,2022-05-10T04:00:00Z,,2022-05-12T16:57:08Z,,0,0,09000064850641ca
FDA-2021-N-1309-0456,FDA,FDA-2021-N-1309,Request for Extension from ITG Cigars Inc.,Other,Request for Extension,2022-05-05T04:00:00Z,2022,5,2022-05-09T04:00:00Z,,2022-05-09T20:20:04Z,,0,0,0900006485052f9f
FDA-2021-N-1309-0457,FDA,FDA-2021-N-1309,"Request for Extension from Cigar Association of America, Inc.",Other,Request for Extension,2022-05-05T04:00:00Z,2022,5,2022-05-09T04:00:00Z,,2022-05-10T11:12:26Z,,0,0,0900006485054940
FDA-2021-N-1309-0458,FDA,FDA-2021-N-1309,Request for Extension from Pipe Tobacco Council,Other,Request for Extension,2022-05-05T04:00:00Z,2022,5,2022-05-09T04:00:00Z,,2022-05-10T11:13:27Z,,0,0,0900006485054979
FDA-2021-N-1309-0048,FDA,FDA-2021-N-1309,Reference 45 FDA Scientific Assessment of the Impact of Flavors in Cigar Products 2022,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:12:08Z,,0,0,0900006485027101
FDA-2021-N-1309-0020,FDA,FDA-2021-N-1309,Reference 17 HHS Preventing Tobacco Use Among Youth and Young Adults 2012,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T14:50:40Z,,0,0,090000648502682f
FDA-2021-N-1309-0056,FDA,FDA-2021-N-1309,Reference 53 Delnevo Cigar Sales in Convenience Stores 2021,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:23:11Z,,0,0,0900006485026d69
FDA-2021-N-1309-0051,FDA,FDA-2021-N-1309,Reference 48 Delnevo A Whole Nother Smoke 2007,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:20:40Z,,0,0,0900006485027103
FDA-2021-N-1309-0097,FDA,FDA-2021-N-1309,Reference 94 Hoffman Flavour Preferences in Youth Versus Adults 2016,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:51:52Z,,0,0,0900006485026f4c
FDA-2021-N-1309-0111,FDA,FDA-2021-N-1309,Reference 108 Rogers Compliance with a Sales Policy on Flavored 2017,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:58:08Z,,0,0,09000064850273f2
FDA-2021-N-1309-0099,FDA,FDA-2021-N-1309,Reference 96 Chen Levels of Mint and Wintergreen 2010,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:54:23Z,,0,0,0900006485026f4e
FDA-2021-N-1309-0103,FDA,FDA-2021-N-1309,Reference 100 Cantrell Cigar Use Progression 2022,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:56:21Z,,0,0,0900006485026f50
FDA-2021-N-1309-0108,FDA,FDA-2021-N-1309,Reference 105 Chamberlain Association Between Tobacco Smoking and Cognitive 2012,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:57:39Z,,0,0,09000064850273ef
FDA-2021-N-1309-0112,FDA,FDA-2021-N-1309,Reference 109 Rogers Changes in Cigar Sales 2020,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:58:19Z,,0,0,09000064850273f3
FDA-2021-N-1309-0116,FDA,FDA-2021-N-1309,Reference 113 Nguyen Intended and Unintended Effects of Restrictions 2015,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:58:56Z,,0,0,09000064850274e2
FDA-2021-N-1309-0076,FDA,FDA-2021-N-1309,Reference 73 Richter Small Group Discussions on Menthol Cigarettes 2008,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:35:21Z,,0,0,0900006485026db6
FDA-2021-N-1309-0055,FDA,FDA-2021-N-1309,Reference 52 Gammon Implementation of a Comprehensive Flavoured Tobacco 2021,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:22:51Z,,0,0,0900006485026d68
FDA-2021-N-1309-0037,FDA,FDA-2021-N-1309,Reference 34 England Developmental Toxicity of Nicotine 2017,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:04:48Z,,0,0,09000064850268cf
FDA-2021-N-1309-0046,FDA,FDA-2021-N-1309,Reference 43 FDA Illicit Trade in Tobacco Products After Implementation 2018,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:10:50Z,,0,0,0900006485026d11
FDA-2021-N-1309-0015,FDA,FDA-2021-N-1309,Reference 12 FDA Memorandum of Summary of Internal Analysis PATH W5 2021,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T14:44:11Z,,0,0,09000064850269f4
FDA-2021-N-1309-0021,FDA,FDA-2021-N-1309,Reference 18 Klein Use of Flavored Cigarettes Among Older Adolescent 2008,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T14:51:17Z,,0,0,0900006485026830
FDA-2021-N-1309-0060,FDA,FDA-2021-N-1309,Reference 57 Casseus Cigarette Smokers Classification of Tobacco Products 2016,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:24:25Z,,0,0,0900006485026d6e
FDA-2021-N-1309-0044,FDA,FDA-2021-N-1309,Reference 41 Peterson The Health Equity Framework 2020,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:09:55Z,,0,0,0900006485026cfe
FDA-2021-N-1309-0047,FDA,FDA-2021-N-1309,Reference 44 FDA Final Summary Report External Letter Peer Review 2022,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:11:36Z,,0,0,0900006485027100
FDA-2021-N-1309-0088,FDA,FDA-2021-N-1309,Reference 85 Avishai Impact and Mechanisms of Cigarillo Flavor 2020,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:38:02Z,,0,0,090000648502731e
FDA-2021-N-1309-0115,FDA,FDA-2021-N-1309,Reference 112 Chaiton Association of Flavoured Cigar Regulations with Wholesale 2019,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:58:45Z,,0,0,0900006485027055
FDA-2021-N-1309-0093,FDA,FDA-2021-N-1309,Reference 90 Mennella Genetic and Environmental Determinants of Bitter Perception 2005,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T15:51:20Z,,0,0,0900006485027383
FDA-2021-N-1309-0159,FDA,FDA-2021-N-1309,Reference 156 Stokes Racial Ethnic Differences in Associations 2021,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T16:46:27Z,,0,0,0900006485027a03
FDA-2021-N-1309-0124,FDA,FDA-2021-N-1309,Reference 121 HHS The Health Consequences of Smoking Nicotine Addiction 1988,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T16:29:14Z,,0,0,090000648502751a
FDA-2021-N-1309-0129,FDA,FDA-2021-N-1309,Reference 126 Lee Inequalities in Tobacco Outlet Density 2017,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T16:31:19Z,,0,0,0900006485027081
FDA-2021-N-1309-0150,FDA,FDA-2021-N-1309,Reference 147 Cantrell Marketing Little Cigars and Cigarillos 2013,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T16:42:08Z,,0,0,09000064850270c4
FDA-2021-N-1309-0128,FDA,FDA-2021-N-1309,Reference 125 Lee A Systematic Review of Neighborhood Disparities 2015,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T16:31:10Z,,0,0,0900006485027080
FDA-2021-N-1309-0148,FDA,FDA-2021-N-1309,Reference 145 Henriksen Neighborhood Variation in the Price of Cheap Tobacco 2017,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T16:41:53Z,,0,0,09000064850270c2
FDA-2021-N-1309-0004,FDA,FDA-2021-N-1309,Reference 1 Tynan Consumption of Cigarettes and Combustible Tobacco 2012,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T14:32:36Z,,0,0,0900006485025c56
FDA-2021-N-1309-0429,FDA,FDA-2021-N-1309,PRIA Reference 117 Touzani Neuropharmacology of Learned Flavor preferences 2010,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:36:16Z,,0,0,0900006485039380
FDA-2021-N-1309-0430,FDA,FDA-2021-N-1309,PRIA Reference 118 Palmatier Nicotine Self Administration with Tobacco Flavor 2020,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:36:40Z,,0,0,0900006485039387
FDA-2021-N-1309-0425,FDA,FDA-2021-N-1309,PRIA Reference 113 Ashley Estimating the Benefits of Public Health Policies 2015,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:33:47Z,,0,0,090000648503937d
FDA-2021-N-1309-0427,FDA,FDA-2021-N-1309,PRIA Reference 115 Massin Measuring Consumer Surplus 2020,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:35:39Z,,0,0,090000648503937f
FDA-2021-N-1309-0408,FDA,FDA-2021-N-1309,PRIA Reference 96 FDA Illicit Trade in Tobacco Products After Implementation 2018,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:30:52Z,,0,0,0900006485038e3a
FDA-2021-N-1309-0426,FDA,FDA-2021-N-1309,PRIA Reference 114 DeCicca Behavioral Welfare Economics 2017,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:35:32Z,,0,0,090000648503937e
FDA-2021-N-1309-0441,FDA,FDA-2021-N-1309,PRIA Reference 129 BLS CPI Data 2022,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:39:53Z,,0,0,09000064850393a5
FDA-2021-N-1309-0446,FDA,FDA-2021-N-1309,PRIA Reference 134 FDA Tobacco User Fee Assessment Formulation 2020,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:42:11Z,,0,0,090000648503998a
FDA-2021-N-1309-0343,FDA,FDA-2021-N-1309,PRIA Reference 31 Census Annual Survey of State Governments,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:20:50Z,,0,0,09000064850381f3
FDA-2021-N-1309-0364,FDA,FDA-2021-N-1309,PRIA Reference 52 HHS Guidelines for Regulatory Impact Analysis 2016,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:24:00Z,,0,0,0900006485038297
FDA-2021-N-1309-0356,FDA,FDA-2021-N-1309,PRIA Reference 44 Friedman A Difference in Differences Analysis of Youth Smoking 2021,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:23:08Z,,0,0,09000064850382c5
FDA-2021-N-1309-0369,FDA,FDA-2021-N-1309,PRIA Reference 57 Ocean Conservancy Together We Are Team Ocean 2020,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:24:35Z,,0,0,0900006485038738
FDA-2021-N-1309-0384,FDA,FDA-2021-N-1309,PRIA Reference 72 DiFranza Measuring the Loss of Autonomy 2002,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:27:02Z,,0,0,090000648503873e
FDA-2021-N-1309-0316,FDA,FDA-2021-N-1309,PRIA Reference 4 Nonnemaker Mortality and Economic Costs from Regular Cigar Use 2014,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:15:33Z,,0,0,0900006485037ca4
FDA-2021-N-1309-0317,FDA,FDA-2021-N-1309,PRIA Reference 5 Gentzke Tobacco Product Use Among Middle and High School 2020,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:15:40Z,,0,0,0900006485037d45
FDA-2021-N-1309-0324,FDA,FDA-2021-N-1309,PRIA Reference 12 HHS Smoking Cessation A Report of the Surgeon General 2020,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:17:54Z,,0,0,0900006485037d88
FDA-2021-N-1309-0226,FDA,FDA-2021-N-1309,Reference 223 Henderson Menthol Enhances Nicotine Reward Related Behavior 2017,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T17:50:40Z,,0,0,0900006485029ddf
FDA-2021-N-1309-0229,FDA,FDA-2021-N-1309,Reference 226 Chang Biomarkers of Exposure Among US Adult 2019,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T17:51:02Z,,0,0,0900006485029df2
FDA-2021-N-1309-0238,FDA,FDA-2021-N-1309,Reference 235 McCormack Cigar and Pipe Smoking and Cancer Risk 2010,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T17:56:21Z,,0,0,0900006485029e0c
FDA-2021-N-1309-0259,FDA,FDA-2021-N-1309,Reference 256 Barnoya Cardiovascular Effects of Secondhand Smoke 2005,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T17:59:47Z,,0,0,0900006485029e56
FDA-2021-N-1309-0219,FDA,FDA-2021-N-1309,Reference 216 Palmatier Nicotine Self Administration with Tobacco Flavor 2020,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T17:45:07Z,,0,0,09000064850299b7
FDA-2021-N-1309-0160,FDA,FDA-2021-N-1309,Reference 157 Johnson Sexual and Gender Minority US Youth Tobacco Use 2019,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T16:50:22Z,,0,0,09000064850275d5
FDA-2021-N-1309-0157,FDA,FDA-2021-N-1309,Reference 154 Wang Tobacco Use Among Middle and High School 2018,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T16:45:15Z,,0,0,0900006485027a02
FDA-2021-N-1309-0191,FDA,FDA-2021-N-1309,Reference 189 Wang Analysis of Pyrolysis Characteristics 2021,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T17:27:24Z,,0,0,0900006485028fe2
FDA-2021-N-1309-0188,FDA,FDA-2021-N-1309,Reference 186 Baker The Effect of Tobacco Ingredients on Smoke Chemistry 2004,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T17:27:00Z,,0,0,0900006485029004
FDA-2021-N-1309-0167,FDA,FDA-2021-N-1309,Reference 164 Corey Little Filtered Cigar Cigarillo and Premium Cigar 2014,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T16:51:22Z,,0,0,0900006485027a51
FDA-2021-N-1309-0174,FDA,FDA-2021-N-1309,Reference 171 Blosnich Disparities in Smoking and Acute Respiratory 2010,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T17:15:56Z,,0,0,0900006485027e75
FDA-2021-N-1309-0189,FDA,FDA-2021-N-1309,Reference 187 Baker The Pyrolysis of Non Volatile Tobacco Ingredients Using 2005,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T17:27:09Z,,0,0,0900006485028fe0
FDA-2021-N-1309-0173,FDA,FDA-2021-N-1309,Reference 170 Schuler Sexual Minority Substance Use Disparities 2020,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T17:15:48Z,,0,0,0900006485027631
FDA-2021-N-1309-0278,FDA,FDA-2021-N-1309,Reference 275 Hamad Association of Low Socioeconomic Status 2020,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:07:00Z,,0,0,090000648502a277
FDA-2021-N-1309-0283,FDA,FDA-2021-N-1309,Reference 280 Prochaska Smoking Mental Illness and Public Health 2017,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:07:37Z,,0,0,090000648502a27a
FDA-2021-N-1309-0284,FDA,FDA-2021-N-1309,Reference 281 Veldhuizen Cause Specific Mortality 2014,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:07:43Z,,0,0,090000648502a30b
FDA-2021-N-1309-0291,FDA,FDA-2021-N-1309,Reference 288 Counotte Development of the Motivational System 2011,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:08:49Z,,0,0,090000648502a3a3
FDA-2021-N-1309-0246,FDA,FDA-2021-N-1309,Reference 243 Shapiro Cigar Smoking in Men and Risk of Death 2000,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T17:58:01Z,,0,0,0900006485029e12
FDA-2021-N-1309-0237,FDA,FDA-2021-N-1309,Reference 234 Ferraroni Socioeconomic Indicators Tobacco and Alcohol 1989,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T17:55:24Z,,0,0,0900006485029e16
FDA-2021-N-1309-0252,FDA,FDA-2021-N-1309,Reference 249 Heineman Increased Risk of Colorectal Cancer 1994,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T17:58:50Z,,0,0,0900006485029e53
FDA-2021-N-1309-0239,FDA,FDA-2021-N-1309,Reference 236 Malhotra Association Between Cigar or Pipe Smoking and Cancer 2017,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T17:56:29Z,,0,0,0900006485029e0d
FDA-2021-N-1309-0271,FDA,FDA-2021-N-1309,Reference 268 Van Dyke Heart Disease Death Rates Among 2018,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:04:47Z,,0,0,090000648502a22c
FDA-2021-N-1309-0281,FDA,FDA-2021-N-1309,Reference 278 Smith Smoking and Mental Illness in the US Population 2014,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:07:22Z,,0,0,090000648502a2be
FDA-2021-N-1309-0298,FDA,FDA-2021-N-1309,Reference 295 IARC Effectiveness of Tax and Price Policies 2011,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:10:04Z,,0,0,090000648502a3e2
FDA-2021-N-1309-0305,FDA,FDA-2021-N-1309,Reference 302 Rostron Estimation of Cigarette Smoking Attributable Mortality 2014,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:12:53Z,,0,0,0900006485035bd4
FDA-2021-N-1309-0301,FDA,FDA-2021-N-1309,Reference 298 FDA Preliminary Regulatory Impact Analysis 2022,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:10:51Z,,0,0,0900006485045297
FDA-2021-N-1309-0342,FDA,FDA-2021-N-1309,PRIA Reference 30 TTB Tax and Fee Rates,Supporting & Related Material,Background Material,2022-05-04T04:00:00Z,2022,5,,,2022-05-04T18:20:44Z,,0,0,09000064850381f2